Nath Bio-Genes (India) Limited — Others, 14-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Nath Bio-Genes (India) Limited has announced a board meeting to submit the Compliance Certificate for the quarter ended 31st March 2025. This submission confirms the processing and acceptance of securities for dematerialization by the registrar, Bigshare Services Pvt. Ltd. The compliance reinstates the company's commitment to regulatory requirements regarding securities and enhances operational transparency.

This update may positively influence investor sentiment by demonstrating adherence to compliance standards, thereby enhancing the company's governance profile. Investors might view this as a sign of stability and operational integrity amid ongoing market dynamics.